home.aspx
 
. https://biotechnology.report/Resources/Whitepapers/fecfb7c3-cb42-41d5-b7d6-d4e5665d5a3b_Epidiolex for Epilepsy Whitepaper.pdf
whitepaper
SHARESHARESHARE
EPIDIOLEX AND EPILEPSY - BIG CHANGES FOR MEDICAL MARIJUANA
With the FDA’s landmark approval of Epidiolex, a cannabidiol used to treat rare, severe pediatric epilepsies, the only obstacle to the legal sale of the drug is DEA reclassification of cannabidiol (CBD). With reclassification likely in the next 90 days, what does it mean for the epilepsy market, as well as the wider market for CBD? DOWNLOAD